ANTIHISTAMINE THERAPY EFFICACY IN PATIENTS WITH CHRONIC IDIOPATHIC URTICARIA



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Estimation of efficacy of antihistamines in patients with various severity levels and various clinical and laboratory variants of chronic idiopathic urticaria (CIU) . Methods. The retrospective study of the anamnestic clinical laboratory findings in 196 patients with CIU was performed. Results. The frequency of patients with full effect of antihistamines was 69%, partial efficacy — 11%, lack of efficacy — 20%. Lack of efficacy was dominated in patients with severe course of the disease and the presence of clinical manifestations of autoimmune disorders, non-specific inflammation and / or signs of cutaneous vasculitis. The full effect of antihistamines was dominated in patients with mild to medium CIU, with a normal clinical blood count and with a negative skin test with autologous serum. Conclusion. Lack of efficacy of of antihistamines in patients with severe course of disease, signs of autoimmune disorders specify on others nonhistamine mediators in CIU pathogenesis and application of the second and third line therapy of CIU.

Full Text

Restricted Access

About the authors

R N Golubchikova

Institute of Immunology

Moscow, Russia

I V Danilycheva

Institute of Immunology

Email: ivdanilycheva@mail.ru
Moscow, Russia

References

  1. Zuberbier T et al. EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009, v. 64, p. 1417-1426.
  2. Wedi B., Kapp A. Evidence-based therapy of chronic urticaria. JDDG. 2007, v. 2, p. 146-154.
  3. Morgan M.M., Khan D.A., Nathan R.A. Treatment for rhinitis and chronic idiopathic urticaria: focus on oral antihistamines. Ann. Pharmacother. 2005, v. 39, p. 2056-2061.
  4. Breneman D.L. Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Ann. Pharmacother. 1996, v. 30, p. 1075-1079.
  5. EAACI/GA2 LEN/EDF guideline: management of urticaria. Allergy. 2006, v. 61, p. 321-331.
  6. Powell R.J. et al. BSACI guidelines for the management of chronic urticaria and angiooedema. Clinical and Experimental Allergy. V 37, p. 631-650.
  7. Российский национальный согласительный документ. Крапивница и ангиоотек: рекомендации для практических врачей. М., 2007, с. 32-33.
  8. Bleehen S.S., Thomas S.E., Greaves M.W et al. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study. Br. J. Dermatol. 1987, v. 117, p. 81-88.
  9. Paul E., Bodeker R.N. Treatment of chronic urticaria with terfenadine and ranitidine: a randomized double-blind study in 45 patients. Eur. J. Clin. Pharmacol. 1986, v. 31, p. 277-280.
  10. Simons FE et al. Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-anta-gonists hydroxyzine and cetirizine in patients with chronic urticaria. J. Allergy Clin. Immunol. 1995, v. 95, p. 685-693.
  11. Wallenstein B., Kersten W Findings on a patient group with urticaria. Allergologie. 1984, v. 7, p. 115-119.
  12. Trachel C., Pichler W.J., Helbling A. Importance of laboratory investigation and trigger factors in chronic urticaria. Schweiz Med. Wochenschr. 1999, v. 129, p. 1271-1279.
  13. Quaranta J.H., Rohr A.S., Rachelefsky G.S. et al. The natural history and response to therapy of chronic urticaria and angioedema. Ann. Allergy. 1989, v. 62, p. 421-424.
  14. Green G.R., Koelsche G.A., Kierland R.R. Etiology and pathogenesis of chronic urticaria. Ann. Allergy. 1965, v. 23, p. 30-36.
  15. Champion R.N. Urticaria: then and now. Br. J. Dermatol. 1998, v. 119, p. 427-436.
  16. Greves M.W., Sabroe R.A. Allergy and the skin: I, urticaria. BMJ. 1988, v. 316, p. 1147-1150.
  17. Kozel M.M.A., Mekkes J.R., Bossuyt P.M.M., Bos J.D. The effectives of history-based diagnostic approach in chronic urticaria and angioedrma. Arch. Dermatol. 1998, v. 134, p. 1575-1580. ,
  18. Grattan C.E.H., O,Donnell F.D.M., Nimmi N. et al. Randomized double-blind study of cyclosporin A in chronic idiopathic urticaria. Br. J. Dermatol. 2000, v. 143, p. 365-372.
  19. Grattan C.E.H., Francis D.M., Slater N.G.P. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet. 1992, v. 339, p.,1078-1080.
  20. O, Donnell B.F., Barr R.M., Kobza Black A. еt al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br. J. Dermatol. 1998, v. 138, p. 101-106.
  21. Zuberbier T. et al. EAACICA2LENEDF guideline: management of urticaria. Allergy. 2006, v. 61, p. 321-331.
  22. Kozel R., Sabroe R. Chronic urticaria and angioedema. Etiology, management and current and future treatment options. Drug. 2004, v. 64, p. 2516-2536.
  23. Stanaland B.E. Treatment of patient with chronic idiopathic urticaria. Clin. Rev. Allergy Immunol. 2002, v. 23, p. 233-241.
  24. http://www.graphpad.com/quickcalcs/ConfInterval2.cfm, Agresti A., Coull B.A. Approximate is better than «Exact» for interval estimation of binomial proportion. The American Statistician. 1998, v. 52, p. 119-126.
  25. Реброва О.Ю. Статистический анализ медицинских данных. М., «Медиа Сфера». 2006, с. 157-159.
  26. Staubach P., Onnen K., Vonend A., Metz M., Siebenhaa. еt al. Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial. Dermatology 2006, v. 212, p. 150-159.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright © Pharmarus Print Media, 2012



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies